tiprankstipranks
PainReform (PRFX)
NASDAQ:PRFX
US Market

PainReform (PRFX) Technical Analysis

Compare
212 Followers

Technical Sentiment

Overall Consensus
Sell
8Bullish
3Neutral
11Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
PainReform’s (PRFX) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting PainReform is a Sell.
PainReform’s (PRFX) 20-Day exponential moving average is 3.17, while PainReform’s (PRFX) share price is $3.15, making it a Sell.
PainReform’s (PRFX) 50-Day exponential moving average is 3.26, while PainReform’s (PRFX) share price is $3.15, making it a Sell.

PainReform (PRFX) Pivot Points

Mar 03, 2025, 02:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.76
2.90
3.00
3.14
3.24
3.38
3.48
Fibonacci
2.90
2.99
3.05
3.14
3.23
3.29
3.38
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PainReform (PRFX) Moving Averages

Mar 03, 2025, 02:46 PM
Period
Simple
Exponential
MA5
3.10Buy
3.14Buy
MA10
3.22Sell
3.15Sell
MA20
3.13Buy
3.17Sell
MA50
3.42Sell
3.26Sell
MA100
3.07Buy
4.40Sell
MA200
6.54Sell
9.93Sell
PainReform’s (PRFX) 10-Day exponential moving average is 3.15, while PainReform’s (PRFX) share price is $3.15, making it a Sell.
PainReform’s (PRFX) 100-Day exponential moving average is 4.40, while PainReform’s (PRFX) share price is $3.15, making it a Sell.
PainReform’s (PRFX) stock price is $3.15 and PainReform’s (PRFX) 50-day simple moving average is 3.42, creating a Sell signal.
PainReform’s (PRFX) stock price is $3.15 and PainReform’s (PRFX) 100-day simple moving average is 3.07, creating a Buy signal.
PainReform’s (PRFX) stock price is $3.15 and PainReform’s (PRFX) 200-day simple moving average is 6.54, creating a Sell signal.

PainReform (PRFX) Technical Indicators

Mar 03, 2025, 02:46 PM
Name
Value
Implied Action
RSI (14)
49.28
Neutral
STOCH (9,6)
14.01
Buy
STOCHRSI (14)
15.52
Buy
MACD (12,26)
-0.03
Sell
ADX (14)
55.99
Sell
Williams %R
-84.36
Buy
CCI (14)
-17.84
Neutral
ATR (14)
0.45
-
Ultimate Oscillator
46.15
Neutral
ROC
2.27
Buy
PainReform’s (PRFX) Relative Strength Index (RSI) is 49.28, creating a Neutral signal.
PainReform’s (PRFX) Trend Strength Indicator (ADX) is 55.99, creating a Sell signal.
PainReform’s (PRFX) Commodity Channel Index (CCI) is -17.84, creating a Neutral signal.
PainReform’s (PRFX) Price Rate of Change (ROC) is 2.27, creating a Buy signal.

FAQ

Is PRFX a Buy, Hold, or Sell?
Based on PRFX’s technical indicators, PRFX is a Sell.
    What is PRFX’s RSI (14)?
    PRFX’s RSI (14) is 49.28, which suggests PRFX is a Neutral.
      What is PRFX’s MACD?
      PRFX’s MACD is -0.03, which suggests PRFX is a Sell.
        What is PRFX’s 5-day moving average?
        PRFX’s 5-day moving average is 3.10, which suggests PRFX is a Buy.
          What is PRFX’s 20-day moving average?
          PRFX 20-day moving average is 3.13, which suggests PRFX is a Buy.
            What is PRFX’s 50-day moving average?
            PRFX’s 50-day moving average is 3.42, which suggests PRFX is a Sell.
              What is PRFX’s 200-day moving average?
              PRFX’s 200-day moving average is 6.54, which suggests PRFX is a Sell.
                What is PRFX’s Williams % R (14)?
                PRFX’s Williams % R (14) is -84.36, which suggests PRFX is a Buy.
                  What is PRFX’s CCI (14)?
                  PRFX’s CCI (14) is -17.84, which suggests PRFX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis